By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Zinfandel Pharmaceuticals Inc.  



Durham  North Carolina    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Diagnostics






Company News
Takeda Pharmaceutical Co. Ltd. (TKPYY) And Zinfandel Pharmaceuticals Inc. To Present Data At Upcoming Alzheimer's Association International Conference® Highlighting Innovative Approaches To Alzheimer's Disease Research And Development 7/10/2014 10:43:47 AM
Takeda (TKPYY) And Zinfandel Pharmaceuticals Inc. To Present Data At Upcoming Alzheimer’s Association International Conference® Highlighting Innovative Approaches To Alzheimer’s Disease Research And Development 7/10/2014 9:28:05 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) and Zinfandel Pharmaceuticals Inc. Initiate Phase 3 TOMMORROW Trial of AD-4833 for the Delay of Onset of Mild Cognitive Impairment Due to Alzheimer's Disease in Subjects Selected Using a Genetic-Based Biomarker Risk Assignment Algorithm 8/26/2013 11:29:50 AM
Takeda and Zinfandel Pharmaceuticals Inc. Announce Results of a Study of the Performance Characteristics of a Genetics-Based Biomarker Risk Assignment Algorithm to Identify Risk of Mild Cognitive Impairment Due to Alzheimer's Disease 7/17/2013 10:15:19 AM
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) and Zinfandel Pharmaceuticals Inc. Sign Licensing Agreement for Alzheimer's Disease Biomarker in Combination with Pioglitazone; Zinfandel to Receive $9M Upfront, Payments of up to $78M 1/11/2011 6:39:41 AM
//-->